Bevespi aerosphere and Hypersensitivity - a phase IV clinical study of FDA data

Summary:

Hypersensitivity is reported as a side effect among people who take Bevespi aerosphere (formoterol fumarate; glycopyrrolate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prednisolone, and have Chronic obstructive pulmonary disease.

The phase IV clinical study analyzes which people have Hypersensitivity when taking Bevespi aerosphere. It is created by eHealthMe based on reports of 1,867 people who have side effects when taking Bevespi aerosphere from the FDA, and is updated regularly.

What is Bevespi aerosphere?

Bevespi aerosphere has active ingredients of formoterol fumarate; glycopyrrolate. eHealthMe is studying from 1,871 Bevespi aerosphere users. Check the latest studies of Bevespi aerosphere.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,748 drugs and 2,916 conditions by eHealthMe. Check the latest studies of Hypersensitivity.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

1,867 people reported to have side effects when taking Bevespi aerosphere.
Among them, 26 people (1.39%) have Hypersensitivity.

Could Bevespi aerosphere cause Hypersensitivity?

Among these 26 people:

How long have people been on Bevespi aerosphere when they have Hypersensitivity? *

What is the gender of people who have Hypersensitivity when taking Bevespi aerosphere? *

female: 90.91 %
male: 9.09 %

What is the age of people who have Hypersensitivity when taking Bevespi aerosphere? *

What are other drugs people take besides Bevespi aerosphere? *

What are other side effects people have besides Hypersensitivity? *

Rashes (redness): 8 people, 30.77%
Nausea (feeling of having an urge to vomit): 7 people, 26.92%
Fatigue (feeling of tiredness): 7 people, 26.92%
Pneumonia: 6 people, 23.08%
Headache (pain in head): 4 people, 15.38%
Limb Injury: 4 people, 15.38%
Pain: 4 people, 15.38%
Procedural Pain: 4 people, 15.38%
Red Blood Cell Sedimentation Rate Increased: 4 people, 15.38%
Rotator Cuff Syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder): 4 people, 15.38%

What are the existing conditions these people have? *

Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 11 people, 42.31%
Immunodeficiency Common Variable: 4 people, 15.38%
Asthma: 3 people, 11.54%
Thyroid Diseases: 2 people, 7.69%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 7.69%
Cardiac Disorder: 2 people, 7.69%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 7.69%
Blood Disorder: 2 people, 7.69%
Sleep Disorder: 1 person, 3.85%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Bevespi aerosphere and have Hypersensitivity?

- Check whether Hypersensitivity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bevespi aerosphere:

Bevespi aerosphere (1,871 reports)

Hypersensitivity treatments and more:

Hypersensitivity (272,618 reports)

How severe was Hypersensitivity and when was it recovered:

Hypersensitivity in Bevespi aerosphere

Expand to all the drugs that have ingredients of formoterol fumarate; glycopyrrolate:

Hypersensitivity and drugs with ingredients of formoterol fumarate; glycopyrrolate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bevespi aerosphere:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypersensitivity:

Hypersensitivity (2,748 drugs)

Browse all the conditions that are associated with Hypersensitivity:

Hypersensitivity (2,916 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on formoterol fumarate; glycopyrrolate (the active ingredients of Bevespi aerosphere) and Bevespi aerosphere (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.